CRITICAL ELEMENTS OF GENETIC EVALUATION AND GENETIC COUNSELING

 

Individual with Turner Syndrome

Date: 6/19/98*

 

Disclaimer

The "Critical Element of Genetic Evaluation and Genetic Counseling" was written and approved by genetic professionals and perinatologists within the state of Washington. The document is to act as an aid to medical geneticists, genetic counselors, and perinatologists who practice within our state. This Critical Element of Genetic Evaluation and Genetic Counseling does not define the applicable standard of care, nor is it intended to dictate an exclusive course for the diagnosis, counseling, treatment or management of genetic conditions or birth defects. The authors acknowledge that appropriate clinical practices may vary depending upon a number of factors including, among others, the needs and choices of the individual patient, the resources available, and limitations unique to the particular institution or type of practice.

 

Information obtained from patient/family

1. Review patient/family questions; reason for referral; knowledge base; perception of disease status and/or risk; what diagnoses have been considered; perceived notion about causation; assess need for professional interpreter:

2a. Using standard symbols, obtain family history (1st and 2nd degree relatives to consultand, and further removed as appropriate). Note ethnic background, consanguinity, ongoing pregnancies, and other significant family history.

b. Additional directed family history:

c. Obtain relevant medical records on patient, including records of 1).appropriate tests/evaluations: karyotype, echocardiogram, renal ultrasound, 2). records bearing on management: thyroid treatment, hormone replacement, schooling issues , and 3). on other family members as needed:

3. Obtain prenatal and perinatal history of patient, including prenatal exposures, pregnancy complications and prenatal testing, when appropriate.

4. Obtain past medical history (including environmental/occupational exposures) focusing on:

ear, eye, learning problems, orthopedic problems

5. Obtain information on growth and development, including school placement. For adult, also obtain information on education, employment and social functioning.

6. Assess family functioning and use of community resources. Assess personal, social, religious, ethnocultural issues.

7. Assess possible ethical concerns, such as confidentiality, non-paternity, insurability, discrimination, prenatal diagnosis:

8 Perform general physical examination of patient and/or other family members present if indicated, with attention to: height, blood pressure

9. Other issues to consider: Age of patient will determine relevant clinical issues (e.g. infant - feeding problems; young child - growth hormone treatment discussion; adolescent - ovarian hormone replacement; infertility/fertility)

 

Information to be provided or discussed with the patient/family

(may occur in a series of multiple patient visits)

1. Summarize information obtained and discuss with patient/family the (possible) diagnosis and the degree of certainty of the diagnosis based on available information.

2. a. Recommend relevant tests/evaluations on patient and/or on other relatives which may include:

patient:

diagnostic:

karyotype - blood (minimum count 20 cells)

 

management:

echo, renal ultrasound, thyroid test q 2 yr in childhood should be considered, q yr in adults

other relatives:

diagnostic:

 


b. Discuss sensitivity/specificity of test(s)/evaluation(s):

3. Discuss the following issues related to natural history: prognosis, developmental outcome/intellectual functioning, anticipated possible medical complications, including pregnancy related risks for affected women if indicated, and preventive measures:

4. Review inheritance pattern (including penetrance and expressivity): sporadic chromosomal for 45, X

5. Assess and discuss recurrence risk for future pregnancies, for affected and at risk individuals. Discuss general background risk for birth defects and recommendations for preconceptional and prenatal use of 0.4 mg folate per day. Include any additional risk based on family history/ethnicity/maternal age/maternal disease/maternal exposure/others:

6a. Discuss reproductive options (e.g. assisted reproductive technologies, adoption, taking risk and no additional pregnancies) when appropriate: not relevant for her parents; for affected woman - adoption, GIFT , no pregnancy with own eggs for affected

b. Discuss prenatal diagnostic options/issues:

(or referral for discussion of)

7. Review management recommendations/options including screening protocols: age dependent

8. Consider referral to: ophthalmology, otolaryngology, cardiology, endocrinology/gyn, psychology/psychiatry as deemed necessary

9. Address psychosocial issues including anticipatory guidance, patient and family reaction to diagnosis, need for community support services.

a. available local/national resources:

b. available written resources for families:

Turner Syndrome Society
15500 Wayzata Blvd.
#811 Twelve Oaks Center
Wayzata, MN 55391
1-800-365-9944

Resolve
1310 Broadway
Sumerville, MA 02144
617-623-1156

booklets - Good Things come in Small Packages
Child Development and Rehabilitation
OHSU/CDRC Publications
P.O. Box 574
Portland, OR 97207
503-494-8699

The X’s and O’s
(order through the Turners Syn Society)

 

10. Address follow-up issues, such as genetic counseling for extended family members, including a plan for relaying test results:

11. Document clinic visit, including persons present, and subsequent substantive contacts (e.g. clinic note, +/- letter to referral source, +/- letter to family; other). Contact referring health care provider as appropriate.

12. Other issues to consider: risk for gonadal blastoma in girls with 45,X/46,XY

13. References and/or other protocols:

Sybert, VP. The Adult Patient with Turner Syndrome in Turner Syndrome in a life span Prospective: Research and Clinical Aspects. Albertsson-Wikland, K. and Ranke, M. (eds) Excerpta Medica, 1995.

Turner Syndrome - A Guide for Physicians. Rosenfeld, MD - available from Turner Syndrome Society

 

 

* This Critical Element of Genetic Evaluation & Genetic Counseling was unanimously approved at a state genetics practitioners meeting on 6/19/98.

 

 

For more information, contact:
Debra Lochner Doyle, MS, CGC
Washington State Department of Health
Genetics Services Section
MS:K17-8
20435 72nd Ave. S Ste. 200
Kent, WA 98032
Phone: (253) 395-6742
Fax: (253) 395-6737
debra.lochnerdoyle@doh.wa.gov